Benjamin Edwards Inc’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $875K | Sell |
75,566
-1,589
| -2% | -$18.4K | 0.01% | 676 |
|
|
2025
Q1 | $674K | Buy |
77,155
+7,229
| +10% | +$63.1K | 0.01% | 705 |
|
|
2024
Q4 | $1M | Buy |
69,926
+11,664
| +20% | +$167K | 0.01% | 610 |
|
|
2024
Q3 | $1.32M | Buy |
58,262
+57,948
| +18,455% | +$1.31M | 0.02% | 530 |
|
|
2024
Q2 | $6K | Buy |
314
+38
| +14% | +$726 | ﹤0.01% | 641 |
|
|
2024
Q1 | $10K | Buy |
276
+132
| +92% | +$4.78K | ﹤0.01% | 643 |
|
|
2023
Q4 | $8K | Sell |
144
-51
| -26% | -$2.83K | ﹤0.01% | 597 |
|
|
2023
Q3 | $8K | Hold |
195
| – | – | ﹤0.01% | 589 |
|
|
2023
Q2 | $11K | Sell |
195
-66
| -25% | -$3.72K | ﹤0.01% | 571 |
|
|
2023
Q1 | $15K | Buy |
261
+35
| +15% | +$2.01K | ﹤0.01% | 549 |
|
|
2022
Q4 | $8K | Buy |
226
+58
| +35% | +$2.05K | ﹤0.01% | 606 |
|
|
2022
Q3 | $5K | Sell |
168
-4
| -2% | -$119 | ﹤0.01% | 618 |
|
|
2022
Q2 | $8K | Buy |
172
+9
| +6% | +$419 | ﹤0.01% | 605 |
|
|
2022
Q1 | $12K | Buy |
163
+4
| +3% | +$294 | ﹤0.01% | 597 |
|
|
2021
Q4 | $24K | Sell |
159
-6
| -4% | -$906 | 0.01% | 498 |
|
|
2021
Q3 | $24K | Sell |
165
-22
| -12% | -$3.2K | 0.01% | 387 |
|
|
2021
Q2 | $37K | Buy |
187
+28
| +18% | +$5.54K | 0.03% | 294 |
|
|
2021
Q1 | $29K | Buy |
+159
| New | +$29K | 0.02% | 287 |
|